ANI Pharmaceuticals, Inc.

This stock has a reasonable momentum. ANI Pharmaceuticals, Inc. has good growth characteristics. ANI Pharmaceuticals, Inc. is not very popular among insiders. ANI Pharmaceuticals, Inc. is a mediocre stock to choose.

ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, a...

News

ANI Pharmaceuticals falls amid Truist downgrade on delayed Alimera deal close

Seeking Alpha - Healthcare ANI Pharmaceuticals falls amid Truist downgrade on delayed Alimera deal close...\n more…

ANI Pharmaceuticals, Alimera Sciences deal set to close Monday

Seeking Alpha - Healthcare ANI Pharmaceuticals, Alimera Sciences deal set to close Monday...\n more…

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Sold by Los Angeles Capital Management LLC

Ticker Report Los Angeles Capital Management LLC trimmed its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 8.0% in the second quarter, HoldingsChannel reports. The firm owned...\n more…

ANI Pharmaceuticals, Alimera Sciences merger to close on September 16

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

Business Wire ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (ANI) and Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera or the Company) today jointly announced that they have scheduled the closing of their transaction...\n more…